Did Black Patients with COVID-19 See Greater Benefits With Novel Mab Therapy?
Hospitalized Black/African-American patients with COVID-19, and a baseline C-reactive protein (CRP) <150 mg/L, experienced a “markedly greater improvement” in survival without ventilation (SWOV), according to an analysis of LIVE-AIR study data. While SWOV at 28 days was improved among all patients with the agent versus placebo (hazard ratio 2.54, 95% CI 1.46-4.41, P=0.0009), the benefit […]